Million Hearts: Prevalence of Leading Cardiovascular Disease Risk Factors — United States, 2005–2012
نویسندگان
چکیده
Each year, approximately 1.5 million U.S. adults have a heart attack or stroke, resulting in approximately 30 deaths every hour and, for nonfatal events, often leading to long-term disability. Overall, an estimated 14 million survivors of heart attacks and strokes are living in the United States. In 2011, the U.S. Department of Health and Human Services, in collaboration with nonprofit and private organizations, launched Million Hearts (http://www.millionhearts.hhs.gov), an initiative focused on implementing clinical and community-level evidence-based strategies to reduce cardiovascular disease (CVD) risk factors and prevent a total of 1 million heart attacks and strokes during the 5-year period 2012-2016. From 2005-2006 to the period with the most current data, analysis of the Million Hearts four "ABCS" clinical measures (for aspirin, blood pressure, cholesterol, and smoking) showed 1) no statistically significant change in the prevalence of aspirin use for secondary prevention (53.8% in 2009-2010), 2) an increase to 51.9% in the prevalence of blood pressure control (in 2011-2012), 3) an increase to 42.8% in the prevalence of cholesterol management (in 2011-2012), and 4) no statistically significant change in the prevalence of smoking assessment and treatment (22.2% in 2009-2010). In addition, analysis of two community-level indicators found 1) a decrease in current tobacco product smoking (including cigarette, cigar, or pipe use) prevalence to 25.1% in 2011-2012 and 2) minimal change in mean daily sodium intake (3,594 mg/day in 2009-2010). Although trends in some measures are encouraging, further reductions of CVD risk factors will be needed to meet Million Hearts goals by 2017.
منابع مشابه
Prevalence of uncontrolled risk factors for cardiovascular disease: United States, 1999-2010.
Heart disease is the leading cause of death in the United States (1). High blood pressure, high cholesterol, and smoking are all risk factors that could lead to cardiovascular disease (CVD) and stroke. The recently announced Million Hearts Initiative is aimed at preventing 1 million heart attacks and strokes over the next 5 years (2–4). This report expands on results previously published (2) by...
متن کاملMillion hearts: strategies to reduce the prevalence of leading cardiovascular disease risk factors--United States, 2011.
Cardiovascular disease (CVD) causes one in three (approximately 800,000) deaths reported each year in the United States. Annual direct and overall costs resulting from CVD are estimated at $273 billion and $444 billion, respectively. Strategies that address leading CVD risk factors, such as hypertension, high cholesterol levels, and smoking, can greatly reduce the burden of CVD. To estimate the...
متن کاملCDC Grand Rounds: the million hearts initiative.
Cardiovascular disease, including heart disease and stroke, is the leading cause of death and disability in the United States. Every year, approximately 2 million persons in the United States have a heart attack or stroke and, as a result of these conditions, approximately 800,000 die from cardiovascular disease. For those persons who do survive a heart attack or stroke, many are faced with ser...
متن کاملعوامل خطر بیماریهای عروق کرونر در سالمندان مقیم یا غیرمقیم خانه سالمندان
Objectives: Cardiovascular disease is the leading cause of death in United States and many parts of the world. This study aimed to evaluate the risk factors of coronary artery disease in residents and non-residents of elderly care homes in Tehran. Methods & Materials: In this descriptive study, about 382 elderly with above 65 years of age participated, from whom 191 were non-resident and 191...
متن کاملBiomarkers of Heart Failure in Myocarditis and Dilated Cardiomyopathy
There are many reviews that discuss the role of biomarkers in cardiovascular disease (CVD) and heart failure (Braunwald, 2008; Chen et al., 2010; Hochholzer et al., 2010), but little information exists regarding the presence and usefulness of biomarkers for heart failure in myocarditis and dilated cardiomyopathy (DCM) patients. Heart failure (HF) is the end consequence of many CVDs including at...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 63 شماره
صفحات -
تاریخ انتشار 2014